FDA Calls All to Shape Drug Approval Fees Through 2032
Published Date: 5/19/2025
Notice
Summary
The FDA is gearing up to renew a law that lets them collect fees from drug companies to help speed up medicine reviews from 2028 to 2032. They’re hosting a public meeting and want your thoughts before the current law ends in September 2027. This means drug companies, patients, and everyone who cares about new medicines should pay attention—because how drugs get approved could change, and money is involved!
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in